The Confirmatory Trial in Comparative-Effectiveness Research
Alan M. Garber, Mark A. Hlatky
New England Journal of Medicine vol. 361 (2009)

A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease
The BARI 2D Study Group, Mark A. Hlatky
New England Journal of Medicine vol. 360, 24 (2009)

The Year in Epidemiology, Health Services Research, and Outcomes Research
Mark A. Hlatky, Paul A. Heidenreich
Journal of the American College of Cardiology vol. 53, 16 (2009)

Coronary Artery Bypass Surgery Compared with Percutaneous Coronary Interventions for Multivessel Disease: A Collaborative Analysis of Individual Patient Data from Ten Randomised Trials
Mark A. Hlatky, Boothroyd DB, Dena M. Bravata, Boersma E, Booth J, Brooks MM, Carrie MD, Clayton TC, Danchin N, Flather M, Hamm CW, Hueb WA, Kahler J, Kelsey SF, King SB, Kosinski AS, Lopes N, Kathryn M. McDonald, Rodriguez A, Serruys P, Sigwart P, Stables RH, Douglas K. Owens, Pocock SJ
The Lancet vol. 10, 1016 (2009)

Incidental Pulmonary Nodules on Cardiac Computed Tomography: Prognosis and Use
Iraberren C, Mark A. Hlatky, Chandra M, Fair JM, Rubin GD, Go AS, Burt JR, Stephen P. Fortmann
American Journal of Medicine vol. 121, 11 (2008)

Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE Study.
Assimes TL, Knowles JW, Basu A, Iribarren C, Southwick A, Tang H, Ashber D, Li J, Fair JM, Rubin GD, Sidney S Sidney S, Stephen P. Fortmann, Go AS, Mark A. Hlatky, Myers RM, Risch N, Quertermous T
Human Molecular Genetics vol. 17, 15 (2008)

Common Polymorphisms of ALOX5 and ALOX5AP and Risk of Coronary Artery Disease
Assimes TL, Knowles JW, Priest JR, Basu A, Volcik KA, Southwick A, Tabor HK, Hartiala J, Allayee H, Grove ML, Tabibiazar R, Sidney S, Stephen P. Fortmann, Go A, Mark A. Hlatky, Iribarren C, Boerwinkle E, Myers R, Risch N, Quertermous T
Human Genetics vol. 123, 4 (2008)

Review: Rosiglitazone Increases Risk of MI But Does Not Differ from Other Drugs for CV Death in Type 2 Diabetes
Mark A. Hlatky, Dena M. Bravata
Evidence-Based Medicine vol. 12 (2007)

Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery
Dena M. Bravata, Allison Gienger, Kathryn M. McDonald, Vandana Sundaram, MV Perez, R Varghese, JR Kapoor, R Ardehali, Douglas K. Owens, Mark A. Hlatky
Annals of Internal Medicine vol. 147, 10 (2007)

Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Surgery
Dena M. Bravata, Allison Gienger, Kathryn M. McDonald, Vandana Sundaram, MV Perez, R Varghese, JR Kapoor, R Ardehali, Douglas K. Owens, Mark A. Hlatky
Annals of Internal Medicine (2007)

Rosiglitazone Increased Heart failure But Did Not Differ from Metformin Plus Sulfonylurea for Other CV Outcomes at Interim Analysis
Mark A. Hlatky, Dena M. Bravata
American College of Physicians Journal Club vol. 147, 3 (2007)